ArticleNature communications2019

Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.

Thomas Oellerich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.